Based in the Genomics Capital of San Diego, OnRamp BioInformatics provides ROSALIND™, the first-ever genomics analysis platform specifically designed for life science researchers to analyze and interpret datasets, without any prior bioinformatics skills.
Named in honor of pioneering researcher Rosalind Franklin, who made a major contribution to the discovery of the double-helix structure of DNA with her famous photograph 51, OnRamp’s ROSALIND™ platform aims to simplify the practice of genomic data interpretation, so that biologists, researchers and drug developers can harness the potential of genomic information from DNA sequencing to microarrays and mass spec, while reducing costs and increasing productivity.
ROSALIND™ puts the researcher into the driver’s seat of data analysis, and helps to free up valuable time for Bioinformatics Cores to offload standard analyses and focus precious resources on more complex challenges. ROSALIND™ brings bioinformatics analyses to the bench scientist by broadly expanding access to genomic and proteomic technologies for cancer research and precision medicine.
Register for Free: https://rosalind.onramp.bio/register
MEET THE EXECUTIVE MANAGEMENT TEAM
Chief Executive Officer
Tim brings 20 years tech experience from Hewlett-Packard, Compaq, TI & DoubleClick with broad executive & operations experience from Corporate Strategy to Finance, Investor Relations, Sales Operations, Marketing and Engineering.
With more than a decade of experience in the enterprise server market, Tim has been recognized as an industry leader and key influencer in the development of next-generation low-power ARM data centers, having led ecosystem development for Hewlett Packard’s ScaleOut Server Business. He also served as VP of Strategy and Operations for HP's Global Enterprise Solutions Business.
Tim holds a B.S. Mechanical Engineering degree from Texas A&M University and is also a graduate of multiple executive programs in Finance, Accounting, Investor Relations and Strategic Marketing with Columbia University, Rice University and University of Michigan.
Chief Technology Officer
Jean joined OnRamp Bio after more than 25 years experience in Genomics, Bioinformatics and Information Technology at Illumina and UCSD. As Associate Director of Enterprise Informatics over the last 5 years, Jean was instrumental to the setup and customer success for Illumina's BaseSpace solution for bioinformatics. He uniquely brings deep experience and knowledge of biology, wet lab operations, microarrays, and next generation sequencing together with advanced bioinformatics, software development and enterprise IT infrastructure.
Jean is recognized as an industry expert in genomics and bioinformatics, and has led hundreds of successful customer deployments of next generation sequencing and informatics systems. At Illumina, he also provided leadership and support for all Enterprise Informatics applications, including BaseSpace Sequence Hub, NextBio tools, Genome Studio, Variant Studio and Variant Interpreter.
Jean holds a Masters in Computer Science from Institut national des Sciences appliquées de Toulouse / INSA Toulouse, and a B.S. Computer Science from IUT de Clermont-Ferrand - Université d'Auvergne.
Chief Revenue Officer
Walt brings over 25 years of experience in sales and business development leadership with Roche Sequencing (Bina Technologies), Danaher, IDBS, Discovery Partners and Beckman.
Over the past 15 years he has lead teams providing software solutions to organizations involved in drug discovery, companion diagnostics and clinical research in the Life Sciences research market.
Walt holds B.S. in Biology and is an active member of the American Chemical Society and American Society for Mass Spectrometry.
Jeremy Davis-Turak Ph.D
VP of BioInformatics
Jeremy earned his Ph.D. in Bioinformatics and Systems Biology in the lab of Dr. Alexander Hoffmann at UCSD, researching kinetic models of co-transcriptional splicing. In his studies, Dr. Davis-Turak developed analyses for RNA-seq, nascent RNA-seq, GRO-seq and MNase-seq that were intimately linked with mechanistic models. He set up the Bioinformatics Core at the San Diego Center for Systems Biology, optimizing pipeline for RNA-seq and ChIP-seq.
Dr. Davis-Turak also has extensive experience analyzing gene expression data from his time working in the Neurogenetics Laboratory at UCLA, where he became an expert in the analysis of Microarrays, Weighted Gene Coexpression Network Analysis, pathways analyses, gene set enrichment and motif analysis. His ambitious goal of enabling researchers without programming experience to ask quantitative questions led to the development of web portals featuring tools to query relational databases of expression data (microarray and sequencing) and perform on-the-fly computational analyses.
VP of Software Engineering
Angel Stanz joins OnRamp with over 20 years of entrepreneurial experience in software engineering and media marketing. This combination of interests provides him with a unique management style for bridging the chasm that often separates technology development and sales channels. Mr. Stanz's impact to dot com startups began by serving as Sr. R&D Engineer for ATCOM/INFO ushering in the "Wi-Fi Lifestyle", co-developing the technology behind hospitality internet access solutions that have now become an expected amenity for business travelers worldwide. This venture was supported by strategic investment from KKR and a partnership with Microsoft, culminating in a $300M exit to Cisco Systems. Since this time, Mr. Stanz has engaged in CEO, CTO, and development roles for creating social, mobile, commerce, and data analysis platforms. These projects have received national media exposure including mentions in the Rolling Stone.
Mr. Stanz currently serves on the board of Jet Genius, a charter aviation platform and holdings company, and contributes as a mentor for Canopy San Diego, an accelerator program supporting seed-stage startups.
BOARD OF DIRECTORS
Richard S. Creager, PhD
Board of Directors
Richard is Director of OnRamp and founder of NaviDx. Dr. Creager also served as senior vice president of Beckman Coulter, Inc. with responsibility for Molecular Diagnostics. Richard also was the company's Chief Scientific Officer. Previously, he led the Immunoassay business for Beckman Coulter.
Board of Directors
Mike is Director of OnRamp and Senior Vice President-Wealth Management at UBS Financial Services in Los Angeles. He focuses on advising Corporations, Foundations, Trusts, and Municipal Governments in investments and finance.
Board of Directors
Dean is Director of OnRamp and a founding partner of Alteryx (currently serving as Chairman and CEO). Dean's leadership and motivational skills, along with his ability to create, communicate and realize a vision, are the driving force behind Alteryx’s considerable growth and its focus on empowering data analysts worldwide. His understanding of business needs and the technology space has helped fuel the impressive SaaS metrics of Alteryx since its inception, with more than 400 employees in 8 facilities around the world.
SCIENTIFIC ADVISORY BOARD
Gary Hardiman, Ph.D, MUSC
Rob Edwards, Ph.D, San Diego State University
Sonia Jain, Ph.D, University of San Diego
Paolo Faraboschi, Ph.D, HP Enterprise Fellow
Allen Day, Ph.D, Google
David Carpentieri, MD, Phoenix Children's Hospital
STRATEGIC ADVISORY BOARD
Shannon Cross, Cross Research
Harry Blount, Discern
David Tucker, Confluent
Larry Wilkelius, Cavium
John Fessler, Santech